← Company Directory
PhaseBio Pharmaceuticals
Work Here? Claim Your Company
Top Insights
  • Contribute something unique about PhaseBio Pharmaceuticals that may be helpful for others (ex. interview tips, choosing teams, unique culture, etc).

  • About

    PhaseBio Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for cardiovascular diseases. Its lead product candidate is bentracimab, a reversal agent for the antiplatelet drug ticagrelor, currently in Phase III clinical trials. The company is also developing treatments for pulmonary arterial hypertension and resistant hypertension. It has a co-development agreement with SFJ Pharmaceuticals X, Ltd. The company filed for Chapter 11 bankruptcy in October 2022.

    Year Founded
    # of Employees
    Estimated Revenue

    Get Verified Salaries in your Inbox

    Subscribe to verified offers. You’ll get the breakdown of compensation details by email. Learn More →

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Featured Jobs

      No featured jobs found for PhaseBio Pharmaceuticals

    Related Companies

    • Stripe
    • Microsoft
    • Netflix
    • Roblox
    • LinkedIn
    • See all companies ➜